Finder

Offers

• Face-to-face consultations
• Video and telephone consultations

About me

Dr Mohammed Abdul-latif is a Consultant Clinical Oncologist treating urological and gynaecological cancers with radiotherapy and systemic therapy, in both the curative and palliative settings. At Mount Vernon Cancer Centre he is also Clinical Lead for brachytherapy, and he offers low dose radiotherapy for a range of benign conditions.

The core of his practice is the day-to-day oncological care of patients with prostate, bladder, cervical, endometrial, vaginal and vulval cancers- from first diagnosis and treatment planning through to follow-up. He delivers radical curative radiotherapy using modern external beam techniques including IMRT, VMAT, image-guided radiotherapy and stereotactic ablative radiotherapy SABR/SBRT, alone or alongside chemotherapy or hormone therapy, and hydrogel spacer SpaceOAR insertion forms a routine part of his prostate radiotherapy pathway.

Palliative care is an equally important part of his work. Short courses of palliative radiotherapy can relieve pain from bone metastases, control bleeding and ease pressure symptoms, and he is closely involved in the urgent management of metastatic spinal cord compression at Mount Vernon. He also prescribes and manages systemic anti-cancer treatment chemotherapy, immunotherapy and targeted therapies with curative or palliative intent, including concurrent chemoradiotherapy.

Complex brachytherapy

Brachytherapy places a radiation source directly within or immediately adjacent to a tumour, allowing a very high dose to be delivered to the target while sparing surrounding healthy tissue. Complex brachytherapy takes this further, using image-guided placement of interstitial needles and catheters into the tumour itself, with the implant designed around each patient's individual anatomy.

Dr Abdul-latif undertakes complex delivery for gynaecological, urological, oesophageal and rectal cancers, including contact radiotherapy, and performs interstitial implants for rarer presentations involving the skin, breast and soft tissues- including a dedicated breast brachytherapy programme for women whose cancer has recurred after previous radiotherapy. Techniques of this kind remain available in only a small number of UK centres.

Low dose radiotherapy for benign conditions

He also offers low dose radiotherapy LDRT- a gentle, outpatient treatment using very small doses of radiation to reduce inflammation and pain in conditions such as osteoarthritis, plantar fasciitis, tennis elbow and Achilles tendinopathy, to slow early Dupuytren's and Ledderhose disease, and to prevent heterotopic ossification after hip surgery, where standard treatments have not helped. More about low dose radiotherapy

Training and academic work

Dr Abdul-latif qualified from Imperial College School of Medicine in 2013, finishing in the top decile of his year, and trained across North London hospitals in general medicine before specialising in clinical oncology. He holds a Postgraduate Diploma PGDip in Oncology and a Doctorate of Medicine MD from the University of Manchester, completed under the supervision of Professor Peter Hoskin, with a thesis on the role of functional MRI in cervical cancer. He publishes regularly and presents at international meetings including ESTRO. He was awarded the Royal College of Radiologists' Kay-Durrant Fellowship, which took him to France and Italy for further training in breast, rectal and head and neck brachytherapy.

He is an Honorary Senior Lecturer at Brunel Medical School, a role that recognises a substantial ongoing contribution to university teaching alongside clinical practice. It involves the delivery and design of undergraduate oncology teaching, supervision and assessment of medical students during their clinical placements, examining, and the supervision of student research projects, as well as supporting the school's wider academic and curriculum development.

Areas of interest

Urological malignancies including prostate and bladder;
Gynaecological malignancies including endometrial, cervical, vaginal and vulval;
External beam radiotherapy (IMRT/VMAT) including stereotactic techniques for prostate;
Chemoradiotherapy;
Interstitial and intercavitary brachytherapy for gynaecological cancers, prostate cancer, rectal cancer (including contact RT), oesophageal cancer and breast cancer;
Salvage and re-irradiation brachytherapy, especially for organ preservation (breast to avoid mastectomy, rectum to avoid a stoma);
Pelvic Radiation disease in the acute and chronic phase

Medical secretaries

• Amy Bignell
• Mount Vernon Cancer Centre Rickmansworth Road Northwood HA6 2RN
• 020 3826 2182
• amy.bignell1@nhs.net